Gao P, Wu X, Zhang FH, Qiao ZL, Yang LJ. Efficacy of Shenmai injection for the treatment of chronic heart failure: A protocol of systematic review.
Medicine (Baltimore) 2020;
99:e20663. [PMID:
32590740 PMCID:
PMC7329011 DOI:
10.1097/md.0000000000020663]
[Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/28/2022] Open
Abstract
BACKGROUND
This study will assess the efficacy and safety of Shenmai injection (SMI) for the treatment of chronic heart failure (CHF).
METHODS
The following electronic bibliographic databases will be searched from inception to the March 25, 2020 without language and publication time limitations: MEDLINE, PUBMED, Cochrane Library, Web of Science, Scopus, WANGFANG, Chinese Biomedical Literature Database, and China National Knowledge Infrastructure. All randomized controlled trials related to the SMI for patients with CHF will be included. All study selection, data extraction, and study quality will be carried out by 2 reviewers. Any disagreements will be solved by a third reviewer through discussion. RevMan 5.3 software will be used for data synthesis and data analysis.
RESULTS
This study will summarize the present evidence of SMI for the treatment of patients with CHF.
CONCLUSION
The findings of this study will determine whether SMI is effective and safety for the treatment of CHF or not.
STUDY REGISTRATION NUMBER
INPLASY202050029.
Collapse